DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN
摘要:
The present invention provides compounds of formula (I) for use in the treatment or prevention of pain. The present invention further provides compounds of formula (I') or (Ibis), as well as pharmaceutical composition comprising thereof. Advantageously, the compounds of formula (I), (I') and (Ibis) show a dual effect, inhibiting the soluble epoxide hydrolase and binding to S1 receptor, two of the targets well-documented as involved in pain. (I)
1-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis
申请人:Leach Colin Andrew
公开号:US20080242666A1
公开(公告)日:2008-10-02
The present invention relates to Compound S of Formula (I).
本发明涉及化合物S,其化学式为(I)。
Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
申请人:Delombaert Stephane
公开号:US20090099184A1
公开(公告)日:2009-04-16
Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.
本发明涉及对可溶性环氧水解酶(sEH)活性的化合物,其组成物和使用和制造的方法。
Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
申请人:De Lombaert Stephane
公开号:US20090111791A1
公开(公告)日:2009-04-30
Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.